Puri S, Kenyon B, Hamrah P
Biomedicines. 2022; 10(8).
PMID: 36009532
PMC: 9406019.
DOI: 10.3390/biomedicines10081985.
Heo Y, Ishimoto N, Jeon Y, Yun J, Ohki M, Anraku Y
PLoS Biol. 2022; 20(8):e3001714.
PMID: 35913979
PMC: 9371267.
DOI: 10.1371/journal.pbio.3001714.
Jiang W, Zheng S
Proc Natl Acad Sci U S A. 2022; 119(21):e2121465119.
PMID: 35594396
PMC: 9173784.
DOI: 10.1073/pnas.2121465119.
Duan J, Shen D, Zhao T, Guo S, He X, Yin W
Nat Commun. 2022; 13(1):1364.
PMID: 35292680
PMC: 8924211.
DOI: 10.1038/s41467-022-29072-3.
Ericson M, Haskell-Luevano C
ACS Chem Neurosci. 2018; 9(6):1235-1246.
PMID: 29714060
PMC: 6042215.
DOI: 10.1021/acschemneuro.8b00151.
Galnon facilitates extinction of morphine-conditioned place preference but also potentiates the consolidation process.
Zhao X, Yun K, Seese R, Wang Z
PLoS One. 2013; 8(10):e76395.
PMID: 24146862
PMC: 3795750.
DOI: 10.1371/journal.pone.0076395.
Positive allosteric modulators to peptide GPCRs: a promising class of drugs.
Bartfai T, Wang M
Acta Pharmacol Sin. 2013; 34(7):880-5.
PMID: 23624758
PMC: 4002610.
DOI: 10.1038/aps.2013.20.
Galanin receptors and ligands.
Webling K, Runesson J, Bartfai T, Langel U
Front Endocrinol (Lausanne). 2012; 3:146.
PMID: 23233848
PMC: 3516677.
DOI: 10.3389/fendo.2012.00146.
Generating orally active galanin analogues with analgesic activities.
Robertson C, Pruess T, Grussendorf E, White H, Bulaj G
ChemMedChem. 2012; 7(5):903-9.
PMID: 22374865
PMC: 4332549.
DOI: 10.1002/cmdc.201100574.
Alarin stimulates food intake and gonadotrophin release in male rats.
Boughton C, Patterson M, Bewick G, Tadross J, Gardiner J, Beale K
Br J Pharmacol. 2010; 161(3):601-13.
PMID: 20880399
PMC: 2990158.
DOI: 10.1111/j.1476-5381.2010.00893.x.
Engineering galanin analogues that discriminate between GalR1 and GalR2 receptor subtypes and exhibit anticonvulsant activity following systemic delivery.
Robertson C, Scholl E, Pruess T, Green B, White H, Bulaj G
J Med Chem. 2010; 53(4):1871-5.
PMID: 20121116
PMC: 2846716.
DOI: 10.1021/jm9018349.
Developing novel antiepileptic drugs: characterization of NAX 5055, a systemically-active galanin analog, in epilepsy models.
White H, Scholl E, Klein B, Flynn S, Pruess T, Green B
Neurotherapeutics. 2009; 6(2):372-80.
PMID: 19332332
PMC: 4402707.
DOI: 10.1016/j.nurt.2009.01.001.
A short estrogen-responsive N-terminal galanin homologue found in rat brain and gut with antiserum raised against rat galanin(1-16).
Hilke S, Hokfelt T, Theodorsson E
Neurochem Res. 2006; 31(2):177-88.
PMID: 16586031
DOI: 10.1007/s11064-005-9007-5.
Synthesis of galmic: a nonpeptide galanin receptor agonist.
Ceide S, Trembleau L, Haberhauer G, Somogyi L, Lu X, Bartfai T
Proc Natl Acad Sci U S A. 2004; 101(48):16727-32.
PMID: 15557002
PMC: 534730.
DOI: 10.1073/pnas.0407543101.
Galanin: neurobiologic mechanisms and therapeutic potential for Alzheimer's disease.
Counts S, Perez S, Kahl U, Bartfai T, Bowser R, Deecher D
CNS Drug Rev. 2002; 7(4):445-70.
PMID: 11830760
PMC: 6741671.
DOI: 10.1111/j.1527-3458.2001.tb00210.x.
Galanin receptor-mediated inhibition of glutamate release in the arcuate nucleus of the hypothalamus.
Kinney G, Emmerson P, Miller R
J Neurosci. 1998; 18(10):3489-500.
PMID: 9570780
PMC: 6793144.
Modes of peptide binding in G protein-coupled receptors.
Berthold M, Bartfai T
Neurochem Res. 1997; 22(8):1023-31.
PMID: 9239758
DOI: 10.1023/a:1022483027858.
Galanin--a neuropeptide with inhibitory actions.
Kask K, Langel U, Bartfai T
Cell Mol Neurobiol. 1995; 15(6):653-73.
PMID: 8719035
PMC: 11563080.
DOI: 10.1007/BF02071130.
Delineation of the peptide binding site of the human galanin receptor.
Kask K, Berthold M, Kahl U, Nordvall G, Bartfai T
EMBO J. 1996; 15(2):236-44.
PMID: 8617199
PMC: 449938.
Characterization of a high-affinity galanin receptor in the rat anterior pituitary: absence of biological effect and reduced membrane binding of the antagonist M15 differentiate it from the brain/gut receptor.
Wynick D, Smith D, Ghatei M, Akinsanya K, Bhogal R, Purkiss P
Proc Natl Acad Sci U S A. 1993; 90(9):4231-5.
PMID: 7683428
PMC: 46480.
DOI: 10.1073/pnas.90.9.4231.